Log in

OTCMKTS:KWBTKiwa Bio-Tech Products Group Stock Price, Forecast & News

-0.01 (-23.64 %)
(As of 05/29/2020 04:00 PM ET)
Today's Range
Now: $0.02
50-Day Range
MA: $0.02
52-Week Range
Now: $0.02
Volume13.94 million shs
Average Volume11.21 million shs
Market Capitalization$5.93 million
P/E RatioN/A
Dividend YieldN/A
Kiwa Bio-Tech Products Group Corporation, through its subsidiaries, develops, manufactures, distributes, and markets bio-technological products for the agricultural market primarily in the People's Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic and compound microbial fertilizers. The company has a strategic relationship with ETS (Tianjin) Biological Science and Technology Development Co., Ltd. to produce bio-fertilizers in the People's Republic of China and internationally; and strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center, as well as China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning, and Institute of Agricultural Economy & Development. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.65 out of 5 stars

Industry, Sector and Symbol

Industry Agricultural chemicals
SectorBasic Materials
Current SymbolOTCMKTS:KWBT



Sales & Book Value

Annual Sales$30.65 million
Cash Flow$0.02 per share
Book Value$0.75 per share


Net Income$340,000.00


Market Cap$5.93 million
Next Earnings Date6/3/2020 (Estimated)
OptionableNot Optionable

Receive KWBT News and Ratings via Email

Sign-up to receive the latest news and ratings for KWBT and its competitors with MarketBeat's FREE daily newsletter.

Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) Frequently Asked Questions

How has Kiwa Bio-Tech Products Group's stock been impacted by COVID-19 (Coronavirus)?

Kiwa Bio-Tech Products Group's stock was trading at $0.0128 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, KWBT stock has increased by 64.1% and is now trading at $0.0210. View which stocks have been most impacted by Coronavirus.

When is Kiwa Bio-Tech Products Group's next earnings date?

Kiwa Bio-Tech Products Group is scheduled to release its next quarterly earnings announcement on Wednesday, June 3rd 2020. View our earnings forecast for Kiwa Bio-Tech Products Group.

How were Kiwa Bio-Tech Products Group's earnings last quarter?

Kiwa Bio-Tech Products Group Co. (OTCMKTS:KWBT) issued its quarterly earnings data on Tuesday, November, 20th. The company reported $0.04 earnings per share for the quarter. The firm had revenue of $7.73 million for the quarter. Kiwa Bio-Tech Products Group had a negative return on equity of 9.08% and a negative net margin of 3.08%. View Kiwa Bio-Tech Products Group's earnings history.

Has Kiwa Bio-Tech Products Group been receiving favorable news coverage?

News articles about KWBT stock have been trending negative on Saturday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Kiwa Bio-Tech Products Group earned a media sentiment score of -2.4 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutKiwa Bio-Tech Products Group.

Who are some of Kiwa Bio-Tech Products Group's key competitors?

What other stocks do shareholders of Kiwa Bio-Tech Products Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kiwa Bio-Tech Products Group investors own include Pharmacyte Biotech (PMCB), BioRestorative Therapies (BRTX), Co-Diagnostics (CODX), FuelCell Energy (FCEL), Ibio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Aurora Cannabis (ACB) and Ascent Solar Technologies (ASTI).

Who are Kiwa Bio-Tech Products Group's key executives?

Kiwa Bio-Tech Products Group's management team includes the following people:
  • Ms. Siuhung Wang-Liu, Chairman, Acting CEO & Acting Pres (Age 41)
  • Mr. Hon Man Yun, Chief Financial Officer (Age 50)
  • Mr. Xiao Qiang Yu, Chief Operating Officer (Age 41)
  • Mr. Yong Lin Song, CTO, Director of Technology & Director (Age 52)
  • Prof. Qi Wang, VP of Technology & Director (Age 53)

What is Kiwa Bio-Tech Products Group's stock symbol?

Kiwa Bio-Tech Products Group trades on the OTCMKTS under the ticker symbol "KWBT."

How do I buy shares of Kiwa Bio-Tech Products Group?

Shares of KWBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Kiwa Bio-Tech Products Group's stock price today?

One share of KWBT stock can currently be purchased for approximately $0.02.

How big of a company is Kiwa Bio-Tech Products Group?

Kiwa Bio-Tech Products Group has a market capitalization of $5.93 million and generates $30.65 million in revenue each year. Kiwa Bio-Tech Products Group employs 63 workers across the globe.

What is Kiwa Bio-Tech Products Group's official website?

The official website for Kiwa Bio-Tech Products Group is www.kiwabiotech.com.

How can I contact Kiwa Bio-Tech Products Group?

Kiwa Bio-Tech Products Group's mailing address is 3200 Guasti Road Suite #100, Ontario CA, 91761. The company can be reached via phone at 909-456-8828 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.